S Melmed, FF Casanueva, AR Hoffman… - Journal of Clinical …, 2011 - Endocrine Soc Objective: The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia. ... Participants: The Task Force consisted of Endocrine Society-appointed experts, a methodologist, and a medical writer. ... Evidence: This evidence-based ... Cited by 7 - Related articles - All 2 versions
AR Hoffman, S Melmed… - Journal of Clinical …, 2011 - Endocrine Soc ... Endocrinol. Metab. 2011 96: 35A-36A Andrew R. Hoffman, Shlomo Melmed and Janet Schlechte Patient Guide to Hyperprolactinemia Diagnosis and Treatment ... PLEASE TEAR HERE The Hormone Foundation's Patient Guide to Hyperprolactinemia Diagnosis and Treatment ... All 3 versions
M Kadmiel, K Fritz-Six, S Pacharne… - Molecular …, 2011 - Endocrine Soc Receptor activity-modifying protein-2 (RAMP2) is a single-pass transmembrane protein that can regulate the trafficking, ligand binding, and signaling of several G protein-coupled receptors (GPCR). The most well-characterized role of RAMP2 is in the regulation of ... Related articles - All 3 versions
K Melkersson, K Berinder… - Neuro endocrinology …, 2011 - ncbi.nlm.nih.gov OBJECTIVES: This study consisting of two subprojects was undertaken to evaluate the effects of hyperprolactinemia on cardiovascular disease (CVD) risk parameters such as anthropometric measures, insulin sensitivity and blood lipids in patients with schizophrenia or related ...
KK Palial, J Drury, L Heathcote, A Valentijin… - Human …, 2011 - ESHRE Abstracts of the 27th Annual Meeting of ESHRE, Stockholm, Sweden, 3 July – 6 July, 2011 ... P-205 Basement membrane integrity is altered in the late secretary phase in women with endometriosis: implications for the pathogenesis of endometriosis KK Palial1, J. Drury1, ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
